Cancer-Killing CRISPR Viruses Destroy Their “Command Centers” From Within
Cancer-Killing CRISPR Viruses Destroy Their “Command Centers” From Within
CRISPR-Cas9, the efficient, cheap, and incredibly effective gene-editing
mechanism, is able to customize the genetic code of any cell in order to do – or
try to do – some truly amazing things.
From snipping out damaged genetic
segments within human embryos to editing HIV out of infected cells, it’s a
revolutionary tool whose potential has only just begun to become clear.
Never miss a talk! SUBSCRIBE to The Science Channel: http://bit.ly/thesciencepodcast .
Read more: http://www.sciencesonic.com .
You may love:
► The Dark Web Is Actually More Of An Archipelago:
► This Is The Maximum Number Of Planets You Can Have In A Solar System Like Ours:
https://www.youtube.com/watch?v=orQ09aqvLiY
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.